This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Li Cui in Biopharmaceutical Compositions
Introduction
Li Cui is an accomplished inventor based in Collegeville, PA (US). He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on antibody variants. His research focuses on developing compositions that can effectively treat interleukin 5 (IL-5) mediated diseases.
Latest Patents
Li Cui holds a patent for "Biopharmaceutical compositions comprising antibody variants." This patent relates to compositions that include antibody variants designed for treating diseases associated with interleukin 5. The patent showcases his expertise in creating effective therapeutic solutions.
Career Highlights
Li Cui is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to advance his research in biopharmaceuticals. His work has been instrumental in the development of new treatments that address critical health issues.
Collaborations
Li Cui collaborates with talented professionals in his field, including Chika Akinseye and Tejinder Kaur Bhinder. These collaborations enhance the innovative potential of his research and contribute to the advancement of biopharmaceutical technologies.
Conclusion
Li Cui's contributions to the field of biopharmaceuticals through his patent on antibody variants highlight his role as a key innovator. His work not only addresses significant medical challenges but also exemplifies the importance of collaboration in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile